SEC Form SC 13G/A filed

2/11/21 3:40:32 PM ET

Medical/Dental Instruments

Health Care

Get the next $SYK alert in real time by email

SC 13G/A 1 filingtext2020.txt SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 Amendment No. |14| Stryker Corporation (Name of Issuer) Common Stock, $.10 Par Value (Title of Class of Securities) 863667101 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,see the Notes). -------------------------------------------------------------------------------- CUSIP No. 863667101 13G/A Page 2 of 6 Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Greenleaf Trust 38-3416104 ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] Not Applicable (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION State of Michigan ________________________________________________________________________________ 5. SOLE VOTING POWER 96,801 NUMBER OF _________________________________________________________________ SHARES 6. SHARED VOTING POWER BENEFICIALLY OWNED BY EACH 20,951,738 REPORTING _________________________________________________________________ PERSON WITH 7. SOLE DISPOSITIVE POWER 91,852 _________________________________________________________________ 8. SHARED DISPOSITIVE POWER 20,956,687 ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 21,048,539 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.6% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON* BK ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! -------------------------------------------------------------------------------- Item 1(a) Name of Issuer: Stryker Corporation Item 1(b) Address of Issuer's Principal Executive Offices: 2825 Airview Boulevard Kalamazoo, MI 49002 Item 2(a) Name of Person Filing: Greeneaf Trust Item 2(b) Address of Principal Business Office or, if None, Residence: 211 South Rose Street Kalamazoo, MI 49007 Item 2(c) Citizenship: State of Michigan Item 2(d) Title of Class of Securities: Common Stock, $.10 Par Value Item 2(e) CUSIP Number: 863667101 -------------------------------------------------------------------------------- Item 3. If this statement is filed pursuant to Rules 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [_] Broker or dealer registered under Section 15 of the Act (15 U.S.C.78o); (b) [X] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C.78c); (c) [_] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C.78c); (d) [_] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C.8a-8); (e) [ ] An Investment Adviser in accordance with Section 240. 13d-1(b)(1) (ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Section 240. 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Section 240. 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C.80a-3); (j) [_] Group, in accordance with Section 240. 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Section 240 13d-1(c), check this box. [ ] Item 4. Ownership. (a) Amount beneficially owned: 21,048,539 (b) Percent of class: 5.6% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 96,801 (ii) Shared power to vote or to direct the vote 20,951,738 (iii) Sole power to dispose or to direct the disposition of 91,852 (iv) Shared power to dispose or to direct the disposition of 20,956,687 -------------------------------------------------------------------------------- Item 5. Ownership of Five Percent or Less of a Class. Not Applicable If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Greenleaf Trust holds these securities in a fiduciary capacity on behalf of various trust and investment management customers, some of whom have the right to receive, or the power to direct the receipt of, dividends from or the proceeds from the sale of these securities Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 11, 2021 (Date) /s/ Michael F. Odar ----------------------------- (Signature) Michael F. Odar, President Greenleaf Trust (Name/Title)

Get the next $SYK alert in real time by email

Recent Analyst Ratings for

$SYK

Date	Price Target	Rating	Analyst
4/13/2026	$410.00	Outperform	Leerink Partners
2/20/2026		Outperform	William Blair
1/27/2026	$387.00	Hold	TD Cowen
1/6/2026	$418.00	Mkt Perform → Outperform	Raymond James
12/19/2025	$440.00	Mkt Perform → Mkt Outperform	Citizens JMP
9/18/2025	$420.00	Neutral	Rothschild & Co Redburn
2/26/2025	$450.00	Buy	Citigroup
12/2/2024	$370.00 → $445.00	Equal-Weight → Overweight	Morgan Stanley

More analyst ratings

SEC Form SC 13G/A filed

2/11/21 3:40:32 PM ET

$SYK

Medical/Dental Instruments

Health Care

Get the next $SYK alert in real time by email

Recent Analyst Ratings for

$SYK

Date	Price Target	Rating	Analyst
4/13/2026	$410.00	Outperform	Leerink Partners
2/20/2026		Outperform	William Blair
1/27/2026	$387.00	Hold	TD Cowen
1/6/2026	$418.00	Mkt Perform → Outperform	Raymond James
12/19/2025	$440.00	Mkt Perform → Mkt Outperform	Citizens JMP
9/18/2025	$420.00	Neutral	Rothschild & Co Redburn
2/26/2025	$450.00	Buy	Citigroup
12/2/2024	$370.00 → $445.00	Equal-Weight → Overweight	Morgan Stanley

More analyst ratings

SEC Form SC 13G/A filed

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$SYK

SEC Form SC 13G/A filed

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$SYK

$SYK
Analyst Ratings

Leerink Partners initiated coverage on Stryker with a new price target

William Blair initiated coverage on Stryker

TD Cowen resumed coverage on Stryker with a new price target

$SYK
Press Releases

Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures

Stryker Launches Pangea Plating System and Completes First Case in Europe

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

$SYK
Insider Trading

President and COO Stiles Spencer S gifted 1,607 shares, decreasing direct ownership by 2% to 76,027 units (SEC Form 4)

VP, Chief Legal Officer Fletcher Robert S sold $1,394,409 worth of shares (4,544 units at $306.87) as part of a pre-agreed trading plan, decreasing direct ownership by 30% to 10,582 units (SEC Form 4)

Director Stryker Ronda E sold $96,792,669 worth of shares (310,000 units at $312.23) (SEC Form 4)

$SYK
SEC Filings

SEC Form SD filed by Stryker Corporation

SEC Form 8-K filed by Stryker Corporation

SEC Form 10-Q filed by Stryker Corporation

$SYK
Leadership Updates

GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors

Stryker showcases continued innovation across orthopaedics at AAOS 2026 Annual Meeting

Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

$SYK
Financials

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Stryker declares an $0.88 per share quarterly dividend

Stryker reports first quarter 2026 operating results

$SYK
Large Ownership Changes